Sign in

RSC Medicinal Chemistry

@rscmedchem.rsc.org
615 followers 435 following 251 posts

The journal for research and review articles in medicinal chemistry and related drug discovery science. Published by @rsc.org 🌐 Website: rsc.li/rscmedchem

PostsRepliesMedia
RSC Medicinal Chemistry @rscmedchem.rsc.org · 30/09/2026
🔓Be sure to read #OpenAccess research by Christian Melander & co. from @notredame.bsky.social & @univofmaryland.bsky.social in our latest issue generating sorafenib analogues that exhibit dual Colistin-potentiating and anti-MRSA activity #medchem Find it in full here🔽 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 28/09/2026
Don't miss the Review behind the inside front cover of our latest issue by Ranjana Pathania et al. from IIT Roorkee discussing AI-enabled discovery of small molecule β-lactamase inhibitors to overcome enzyme diversity and resistance evolution #medchem doi.org/10.1039/d6md...
001
RSC Medicinal Chemistry @rscmedchem.rsc.org · 24/09/2026
📢Our latest issue is now online! 🔓Check out the #OpenAccess Review behind the cover by Ellen E. Hyde & @andrewbeekman.bsky.social from @uniofeastanglia.bsky.social looking at protein–protein interaction inhibitors in the human proteome #medchem doi.org/10.1039/d6md...
011
RSC Medicinal Chemistry @rscmedchem.rsc.org · 21/09/2026
Take a look in our latest issue at research by Kanaka Hettiarachchi & co. describing an integrated platform for accelerating therapeutic macrocyclic peptide purification in high-throughput medicinal chemistry #medchem 📍Merck & Co. doi.org/10.1039/d6md...
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 18/09/2026
Be sure to read a review from Zahoor Ahmad et al. at CSIR-IIIM in our latest issue looking at strategies for designing polypharmacological agents against multi-drug-resistant tuberculosis #medchem Find the full article on our website🔽 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 16/09/2026
🔓Don't miss #OpenAccess research by Elena Cichero & co. from University of Genoa probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays #medchem Check it out in full below👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 14/09/2026
Check out research in our latest issue from Qidong You, Lei Wang et al. at China Pharmaceutical University reporting the discovery of DDO-4279 as a PP5 degrader for the treatment of obesity #medchem Read the full paper here🔽 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 11/09/2026
Take a look at this Opinion article by Matthew W. D. Perry & Rhona J. Cox in our latest issue describing a game to communicate the iterative optimisation of multiple parameters in medicinal chemistry to wider audiences #medchem 📍 @astra-zeneca.bsky.social doi.org/10.1039/d6md...
051
RSC Medicinal Chemistry @rscmedchem.rsc.org · 09/09/2026
Be sure to read in our latest issue a paper from Héctor R. Morbidoni, Guillermo R. Labadie & co. at IQUIR-CONICET exploring the antimycobacterial profile of N-alkyl imidazoles #medchem Find it in full on our website🔽 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 07/09/2026
Don't miss this research by Bahaa G. M. Youssif et al. from Assiut University in our latest issue developing a series of novel methylene disalicylic acid derivatives targeting DNA gyrase and topoisomerase IV #medchem Check out their full report below👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 04/09/2026
Check out this review from Nicholas S. O'Brien & Adam McCluskey at the University of Newcastle providing an overview of the last twenty years of quinazolines as tubulin polymerisation inhibitors #medchem Read the full article here🔽 doi.org/10.1039/d5md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 02/09/2026
📢We’re excited to announce that nominations for our 2027 Emerging Investigator Lectureship are open Details about how to nominate: www.rsc.org/standards-an... We’re looking for up-and-coming researchers in drug discovery within 12 yrs of their PhD. Nominate before 2 November! #chemsky #medchem 🧪
043
RSC Medicinal Chemistry @rscmedchem.rsc.org · 31/08/2026
🔓Take a look at #OpenAccess research in our latest issue by Zsolt Szakonyi et al. on the synthesis, molecular modelling and evaluation of (−)-isopulegol-based 2,4-diaminopyrimidines as aurora kinase inhibitors #medchem 📍University of Szeged, Vietnam National University doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 28/08/2026
Be sure to read this review by Cong-Jun Liu & co. from Zhengzhou University of Technology in our latest issue discussing strategic selection of linker attachment points in PROTACs #medchem Find the full article on our website👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 26/08/2026
📢We are delighted to announce our #OpenCall for papers to our Covalent Inhibitors & Probes themed collection #chemsky #medchem Guest Editors: @lynjoneschembio.bsky.social, Brian Lanman & Hannah Stewart Deadline: 31st January 2027 Find out more🔽 www.rsc.org/publishing/j...
011
RSC Medicinal Chemistry @rscmedchem.rsc.org · 24/08/2026
Don't miss this research in our latest issue from Zhengqiang Wang et al. @univofminnesota.bsky.social & @tamu.bsky.social reporting 3-hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase inhibitors #medchem Check it out in full here🔽 doi.org/10.1039/d6md...
111
RSC Medicinal Chemistry @rscmedchem.rsc.org · 21/08/2026
📢Our latest issue is now online! 🔓Check out the #OpenAccess review behind the cover by Mayasah Al-Nema & co. from University of British Columbia discusseingrecent applications of computational techniques in the discovery of flavivirus inhibitors #medchem doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 19/08/2026
We are delighted to be co-chairing the AI in Medicinal Chemistry track at ELRIG Drug Discovery 2026 at ExceL London on 14-15 October! #ELRIGDD26 Looking forward to hearing the latest work in this exciting area of drug discovery. Don't miss your chance to attend with free registration bit.ly/4aSqgXA
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 17/08/2026
Be sure to read research from Rajnish Kumar, Shashikala Verma, Arunava Manna et al. at Banaras Hindu University in our latest issue describing novel complex naphthalimide–ciprofloxacin hybrids as antimicrobial agents #medchem Find it in full below🔽 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 14/08/2026
🔓Don't miss this #OpenAccess review in our latest issue by Li-Ping Bai & co. from Macau University of Science and Technology discussing the recent advances in piperine and its derivatives as potential anticancer agents #medchem Check out the full article on our website👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 12/08/2026
Check out research from Ahmed M. El-Saghier et al. at Sohag University in our latest issue on the development of novel sulfonamide-embedded 1,2,4-triazinone derivatives in TGF-β-activated hepatic stellate cells #medchem Read it in full here🔽 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 10/08/2026
🔓Take a look in our latest issue at research by Céline Olivier, Samir Amrane & co. reporting a new class of G-quadruplex ligands with anti-HIV-1 properties #medchem 📍 @univbordeaux.bsky.social doi.org/10.1039/d5md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 07/08/2026
🔓Be sure to read #OpenAccess research from Arun K. Ghosh et al. @purduechemistry.bsky.social in our latest issue describing novel SARS-CoV-2 Mpro inhibitors containing tetrahydroisoquinoline-3-carboxamides as P2 ligands #medchem Find it in full here👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 05/08/2026
Don't miss research in our latest issue from Hongyan Li, Hongzhe Sun & co. at the University of Hong Kong showcasing the use of a bismuth drug as an antibiotic adjuvant to inhibit biofilm formation #medchem Check it out on our website🔽 doi.org/10.1039/d6md...
121
RSC Medicinal Chemistry @rscmedchem.rsc.org · 03/08/2026
🔓Check out this review by Celine Cano et al. from @newcastleuni.bsky.social in our latest issue providing insights into the discovery and optimisation of DNA-PK inhibitors #medchem Read the full article below👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 31/07/2026
Take a look in our latest issue at research from Toshio Morikawa, Genzoh Tanabe & co. investigating the structure activity relationship of the indole 2-S-,3-O-bis-glucoside calanthoside #medchem 📍Kindai University doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 29/07/2026
Be sure to read this review from Zihao Liu & Zhiguang Yang at Jilin University in our latest issue discussing the progress of histone deacetylase-based dual inhibitors in non-small cell lung cancer therapy #medchem Find their full article on our website👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 27/07/2026
🔓Don't miss #OpenAccess research in our latest issue by Ioannis K. Kostakis & co. from the University of Athens reporting novel hydroxytyrosol esters as potential anti-amyloid and neuroprotective agents for Alzheimer's disease #medchem Check it out in full here🔽 doi.org/10.1039/d6md...
021
RSC Medicinal Chemistry @rscmedchem.rsc.org · 24/07/2026
📢Our latest issue is now online! Check out the research behind the cover by Oleksandr O. Grygorenko & co. from Enamine & University of Kyiv describing the structure–activity relationships in a series of dihydrouracil–JQ1 conjugates #medchem doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 20/07/2026
Be sure to read this review by Mahdi Gallala et al. from Monastir University in our latest issue discussing the recent advances in the development of acridine-based hybrids with antiproliferative activity #medchem Find their full article below👇 doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 17/07/2026
🔓Don't miss this #OpenAccess research in our latest issue from @danielecastagnolo.bsky.social & co. @ucl.ac.uk & @kingscollegelondon.bsky.social describing light-controlled inhibition of Gram-positive bacteria by photoswitchable amphiphilic lipids #medchem Check it out here🔽 doi.org/10.1039/d6md...
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 15/07/2026
Take a look at this review from Yan Li, Honghua Zhang & co. in our latest issue looking at small-molecule therapeutics for diabetic retinopathy #medchem 📍National University of Singapore & Lanzhou University doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 13/07/2026
Be sure to read this paper in our latest issue by Srikanta Patra, Debasis Manna et al. at IIT Guwahati & IIT Bhubaneswar addressing multidrug-resistant bacterial infections with iridium-based theragnostic agents #medchem Find it in full below👇 doi.org/10.1039/d6md...
111
RSC Medicinal Chemistry @rscmedchem.rsc.org · 10/07/2026
🔓Don't miss in our latest issue #OpenAccess research by Gonzalo Rodriguez-Berriguete, Christopher J. Schofield, Geoff S. Higgins & co. @ox.ac.uk reporting structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors #medchem Check it out here🔽 doi.org/10.1039/d5md...
110
RSC Medicinal Chemistry @rscmedchem.rsc.org · 08/07/2026
Check out this review by Fengxia Sun, Yunfei Da et al. from Tianjin University in our latest issue discussing the targets, pharmacological properties and SAR studies of sulfone and sulfoxide-containing pharmaceuticals #medchem Read it in full on our website🔽 doi.org/10.1039/d5md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 06/07/2026
Take a look in our latest issue at research by Patrícia Dias Fernandes & co. reporting new terpenyl–cinnamoyl–hydrazone analogues of cannabidiol with potent antinociceptive effect #medchem 📍 @ufrjoficial.bsky.social & @unifalmg.bsky.social doi.org/10.1039/d6md...
000
RSC Medicinal Chemistry @rscmedchem.rsc.org · 03/07/2026
🔓Be sure to read this #OpenAccess research from Shinya Oishi et al. at Kyoto Pharmaceutical University in our latest issue identifying minimal fusion inhibitors targeting measles virus F protein #medchem Find their full report on our website👇
doi.org
Identification and structure–activity relationship analysis of minimal fusion inhibitors targeting measles virus F protein
Although measles has been effectively controlled by vaccination, sporadic outbreaks still occur worldwide, highlighting the need for antiviral agents as complementary measures to achieve sustained…
020
RSC Medicinal Chemistry @rscmedchem.rsc.org · 01/07/2026
🔓Don't miss this #OpenAccess review in our latest issue by Martin R. Gill from Swansea University discussing the mechanisms and therapeutic implications of the relationship between Ruthenium(ii) polypyridyl complexes and the DNA damage response #medchem Check it out in full🔽
doi.org
Ruthenium(II) polypyridyl complexes and the DNA damage response: mechanisms and therapeutic implications
Ruthenium(ii) polypyridyl complexes (RPCs) have generated substantial interest due to their biomolecular binding capabilities, favourable photophysical properties, and anticancer activity. DNA is…
120
RSC Medicinal Chemistry @rscmedchem.rsc.org · 29/06/2026
🎉We were delighted to have @fleurmferguson.bsky.social's 2026 RSC Medicinal Chemistry Emerging Investigator Lectureship presented at the Induced Proximity Modalities & Therapeutics GRC this month! A huge congratulations to Fleur again on being selected for this year's Lectureship #chemsky #medchem
181
RSC Medicinal Chemistry @rscmedchem.rsc.org · 25/06/2026
📢Our latest issue is now online! Check out the article behind the cover by Nikolai Petrovsky, Janardhan Banothu & co. at NIT Calicut & Panjab University describing bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as TLR2 agonists #medchem pubs.rsc.org/en/content/a...
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 21/06/2026
Take a look in our latest issue at this review from Philip E. Thompson & co. highlighting the diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors #medchem 📍 @monashuniversity.bsky.social
pubs.rsc.org
Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors
The melanocortin receptor (MCR) family consists of five G protein-coupled receptors (MC1R-MC5R) that are activated by peptide hormones α, β and γ-MSH and ACTH. These receptors are involved in diverse…
020
RSC Medicinal Chemistry @rscmedchem.rsc.org · 19/06/2026
Be sure to read a paper by Lei Wang, Engin U. Akkaya et al. from the Dalian University of Technology in our latest issue reporting hypoxia-triggered dichloroacetate delivery with effective reversal of cancer cell reprogramming #medchem Find the full article here🔽
pubs.rsc.org
Hypoxia-triggered dichloroacetate delivery with effective reversal of cancer cell reprogramming
Dichloroacetate (DCA) is a known inhibitor of pyruvate dehydrogenase kinase, which is part of the key enzyme complex in metabolic reprogramming of cancer cells. In this work, we structurally modified…
010
Reposted by RSC Medicinal Chemistry
Royal Society of Chemistry @rsc.org · 17/06/2026
We're excited to announce the winners of our 2026 RSC Prizes! More than 60 talented individuals and teams from around the globe are being celebrated today for their work on everything from solar energy and drug discovery to materials chemistry and AI. 👉 rsc.li/3SgSapw #RSCPrizes #ChemSky
A gold medal with a red ribbon is centered, featuring various scientific illustrations, including a mountain, laboratory equipment, and a molecule. "RSC Prizes" is written in the top left corner, and the "Royal Society of Chemistry" logo is on the top right. The background is black with scattered gold dots. Text at the bottom reads, "Celebrate with us #RSCPrizes.
02115
RSC Medicinal Chemistry @rscmedchem.rsc.org · 17/06/2026
Don't miss this review in our latest issue from Rahul Kumar & Mohd Yeshab Ansari at CSIR-IHBT & CSIR-CDRI discussing the synthesis and therapeutic potential of antimicrobials in oncology #medchem Check it out in full on our website👇
pubs.rsc.org
Beyond infection control: exploring the therapeutic potential of antimicrobials in oncology and their synthetic perspectives
The repurposing of FDA-approved antimicrobial agents for oncology presents a promising therapeutic strategy to accelerate drug development and enhance clinical outcomes in cancer therapy. This…
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 15/06/2026
🔓Check out #OpenAccess research by Paul M. Dunman, Christian Melander & co. @notredame.bsky.social & @urochester.bsky.social in our latest issue exploring a benzothiophene scaffold for use as adjuvants with β-lactam antibiotics against MRSA #medchem Find in full below🔽
pubs.rsc.org
Exploration of a benzothiophene scaffold for use as adjuvants with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus
Rising antibiotic resistance coupled with diminishing investment in antibiotic development has led to limited treatment options for multi drug-resistant bacterial infections. Penicillin binding…
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 12/06/2026
Take a look at a paper in our latest issue from Mansour S. Alturki, Marwa F. Ahmed, Atiah H. Almalki et al. on the design, synthesis & anticancer evaluation of novel pyrrole–pyrazoline/chalcone hybrids #medchem 📍Imam Abdulrahman Bin Faisal University, Taif University
pubs.rsc.org
Design, synthesis, and anticancer evaluation of novel pyrrole–pyrazoline/chalcone hybrids: in vitro and computational insights into EGFR inhibition
A novel series of pyrrole–pyrazoline/chalcone hybrids were designed, synthesized and evaluated for antiproliferative activity to target epidermal growth factor receptor (EGFR) inhibition. All the…
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 10/06/2026
Be sure to read research in our latest issue by Jeffrey W. Strovel, Steven Fletcher & co. @univofmaryland.bsky.social describing lead optimization of a quinolin-2(1H)-one-based inhibitor of the BRD4 member of BET protein family #medchem Find their full report here👇
pubs.rsc.org
Lead optimization of 5jc21 (CG13250), a quinolin-2(1H)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteins
The inhibition of the BET BRD4 protein has rapidly emerged as an indirect means of inhibiting the intrinsically disordered c-Myc proto-oncoprotein, a “holy grail” in oncology. Herein, we conducted…
010
RSC Medicinal Chemistry @rscmedchem.rsc.org · 08/06/2026
Don't miss this review from Fule Wu, Muneeb Ur Rehman, Sihui Long et al. at the Wuhan Institute of Technology in our latest issue providing a holistic view of the pharmacological landscape of carbolines #medchem Check it out on our website🔽
pubs.rsc.org
Pharmacological landscape of carbolines: a holistic view
Natural resources have served as a cornerstone for the discovery of innovative pharmaceutical compounds for millennia. Among the diverse natural compounds demonstrating significant pharmacological…
031
RSC Medicinal Chemistry @rscmedchem.rsc.org · 05/06/2026
🔓Check out this #OpenAccess paper in our latest issue by Zafer Asım Kaplancıklı & co. from Anadolu University reporting quinoline/thiazole compounds as selective acetylcholinesterase inhibitors #medchem Read it in full below👇
pubs.rsc.org
Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment
Acetylcholine (ACh), acetylcholinesterase enzyme (AChE), and AChE inhibition are of great importance in the treatment of neurodegenerative diseases. When it comes to AChE inhibition, FDA-approved…
020
RSC Medicinal Chemistry @rscmedchem.rsc.org · 03/06/2026
Take a look at research by Adam McCluskey et al. in our latest issue investigating the clathrin inhibitory effects of substituted naphthoquinones #medchem 📍University of Newcastle, University of Queensland, @sydney.edu.au & @fmp-berlin.de
pubs.rsc.org
From bolinaquinone, a marine hydroxyquinone sesquiterpene, to naphthoquinones with clathrin inhibitory effects
Bolinaquinone (BLQ, 1), a hydroxyquinone sesquiterpene, has been reported to inhibit clathrin mediated endocytosis. As there is no reported clathrin IC50 or commercial source of BLQ, we examined the…
020